COMMISSIONER KESSLER TRAVEL RECORDS COULD BE SUBJECT OF OVERSIGHT SUBCMTE. SCRUTINY IN 1997; GOP CONGRESS LIKELY TO KEEP PRESSURE ON AGENCY IN NEXT SESSION
This article was originally published in The Gray Sheet
Executive Summary
An internal FDA review of Commissioner David Kessler's travel expense reports is a likely topic for congressional oversight of the agency in 1997.